Trial intelligence / Profile preview

Dexmedetomidine on QTc in Robotic Prostatectomy

NCT02536014Completed

Sponsor
Yonsei University
Start
Aug 2015
Primary completion
Jan 2016
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of dexmedetomidine in cardiac arrhythmia (2 arms), sponsored by Yonsei University. Primary endpoint: Heart-rate Corrected QT Interval. Started Aug 2015; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

cardiac arrhythmia

Beyond the preview

Go deeper on NCT02536014.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02536014.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call